Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 5/20 | 1.00 |
| ▸ | IP6K2 | Q9UHH9 | 4/20 | 1.00 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 1.00 |
| ▸ | MAOB | P27338 | 3/20 | 0.89 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.89 |
| ▸ | MAPT | P10636 | 10/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.82 |
| ▸ | NPC1 | O15118 | 5/20 | 0.82 |
| ▸ | TSHR | P16473 | 3/20 | 0.82 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.82 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.82 |
| ▸ | MEN1 | O00255 | 8/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.80 |
| ▸ | TP53 | P04637 | 5/20 | 0.80 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.80 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Genkwanin SCHEMBL29445006 | 1.00 | FLT3 (1.00) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| Apigenin Dimethylether SCHEMBL29392759 | 0.94 | MAOB (1.00) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| Apigenin Dimethylether SCHEMBL1176691 | 0.94 | MAOB (1.00) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| Techtochrysin SCHEMBL29494561 | 0.90 | MAPT (1.00) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| Techtochrysin SCHEMBL249043 | 0.90 | MAPT (1.00) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| SCHEMBL311530 | 0.89 | ABCB1 (0.82) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| SCHEMBL29978577 | 0.89 | ABCB1 (0.82) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| SCHEMBL30074462 | 0.89 | PLG (1.00) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| SCHEMBL4203893 | 0.89 | PLG (1.00) | FLT3IP6K2MKNK2MAOBCYP19A1 | |
| Acacetin SCHEMBL107712 | 0.89 | CYP1B1 (1.00) | FLT3IP6K2MKNK2MAOBCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3539550-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES WHICH INCLUDES FLOWER EXTRACT OF DAPHNE GENKWA AS ACTIVE INGREDIENT | KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) | 2026-03-04 | — | — | EP | claimed |
| CN-121575069-A | Application of glycosyltransferase or mutant thereof in biosynthesis of flavone 5-O glycoside | 湖北中医药大学 | 2026-02-27 | — | — | CN | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| CN-120078850-A | Sargentodoxa cuneata-herba patriniae extract, and pharmaceutical composition and application thereof | 扬州大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119925341-A | Application of genkwanin in preparation of antidepressant drugs | 郑州大学第一附属医院 | 2025-05-06 | — | — | CN | claimed |
| CN-119818477-A | Application of genkwanin in preparing medicament for treating diabetic ulcer | 上海市皮肤病医院 | 2025-04-15 | — | — | CN | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | claimed |
| EP-4518685-A1 | METHOD OF PREVENTING AND/OR INHIBITING THE OUTGROWTH, SPORULATION, GERMINATION OR TOXIN FORMATION OF CLOSTRIDIUM | Givaudan SA (CH) | 2025-03-12 | — | — | EP | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| CN-1572755-A | Cherry leaf extract and its preparation method | ZHENG YUAN (CN) | 2005-02-02 | — | — | CN | claimed |
| US-20030166583-A1 | Such as epicatechin coadministered with retinoic acid; bioavailability | HU, OLIVER YOA-PU (TW) | 2003-09-04 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-0290442-A4 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. | CHEMEX PHARMACEUTICALS INC (US) | 1990-07-03 | — | — | EP | claimed |
| EP-0290442-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-11-17 | — | — | EP | claimed |
| US-4774229-A | ANTITUMOR AGENTS, SKIN DISORDERS, CANCER TREATMENT | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-09-27 | — | — | US | claimed |
| WO-1988003805-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-06-02 | — | — | WO | claimed |
| WO-1987006833-A1 | MODIFICATION OF PLANT EXTRACTS FROM ZYGOPHYLLACEAE | CHEMEX PHARMACEUTICALS, INC. (US) | 1987-11-19 | — | — | WO | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166583-A1 | Such as epicatechin coadministered with retinoic acid; bioavailability | CYP51A1, CYP2E1, CYP7A1 | FLT3 3141/4885IP6K2 4110/4885MKNK2 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.